TET2 and lymphoma: The next-generation sequencing performed on the sample confirms that the predominant T-cell clones in this lymphoma contained CAR-T cell fusion mRNA, with potential driver mutations found in TET2, BRAF (V600E), PPM1D, ATM, and RUNX1.